CERT

Certara (CERT)

About Certara (CERT)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Details

Daily high
$5.58
Daily low
$5.38
Price at open
$5.38
52 Week High
$13.88
52 Week Low
$4.45
Market cap
830.7M
Dividend yield
0.00%
Volume
128,439
Avg. volume
4.4M
P/E ratio
-56.03

Certara News

Details

Daily high
$5.58
Daily low
$5.38
Price at open
$5.38
52 Week High
$13.88
52 Week Low
$4.45
Market cap
830.7M
Dividend yield
0.00%
Volume
128,439
Avg. volume
4.4M
P/E ratio
-56.03